BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32457478)

  • 1. Temperatures, diagnostics and treatment in pediatric cancer patients with fever in neutropenia, NCT01683370.
    Brack E; Wagner S; Stutz-Grunder E; Agyeman PKA; Ammann RA
    Sci Data; 2020 May; 7(1):156. PubMed ID: 32457478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer.
    Wagner S; Brack EK; Stutz-Grunder E; Agyeman P; Leibundgut K; Teuffel O; Ammann RA
    PLoS One; 2018; 13(2):e0193227. PubMed ID: 29462193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer.
    Ammann RA; Teuffel O; Agyeman P; Amport N; Leibundgut K
    PLoS One; 2015; 10(2):e0117528. PubMed ID: 25671574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperatures and blood counts in pediatric patients treated with chemotherapy for cancer, NCT01683370.
    Lavieri L; Koenig C; Teuffel O; Agyeman P; Ammann RA
    Sci Data; 2019 Jul; 6(1):108. PubMed ID: 31270328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study.
    Binz P; Bodmer N; Leibundgut K; Teuffel O; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2013 May; 60(5):799-805. PubMed ID: 23193083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial.
    Koenig C; Bodmer N; Agyeman PKA; Niggli F; Adam C; Ansari M; Eisenreich B; Keller N; Leibundgut K; Nadal D; Roessler J; Scheinemann K; Simon A; Teuffel O; von der Weid NX; Zeller M; Zimmermann K; Ammann RA
    Lancet Child Adolesc Health; 2020 Jul; 4(7):495-502. PubMed ID: 32497520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
    Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
    J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993-2012.
    Zermatten MG; Koenig C; von Allmen A; Agyeman P; Ammann RA
    Sci Data; 2019 Jan; 6():180304. PubMed ID: 30644854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012.
    von Allmen AN; Zermatten MG; Leibundgut K; Agyeman P; Ammann RA
    Sci Data; 2018 Mar; 5():180038. PubMed ID: 29534058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
    Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
    Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
    Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
    Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
    Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fever with chemotherapy induced neutropenia].
    Conen K
    Ther Umsch; 2014 Jan; 71(1):17-22. PubMed ID: 24394205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA.
    Koenig C; Morgan J; Ammann RA; Sung L; Phillips B
    Syst Rev; 2019 Apr; 8(1):82. PubMed ID: 30944024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
    Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
    Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early hospital discharge of children with fever and neutropenia: a prospective study.
    Wacker P; Halperin DS; Wyss M; Humbert J
    J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.